Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study.

Notably, the PFS in patients with advanced HL was significantly inferior to that in early favorable disease (hazard ratio [HR] 4.30, 95% CI: 1.01–18.26, p = 0.048; Figure 2A ), but in terms of OS, the difference between early favorable and advanced HL did not reach statistical significance (HR 3.43, 95% CI: 0.79–14.83, p = 0.099; Figure 2B ).

also in 111,027 other papers